MedPath

Measuring the effects of continuous dopaminergic stimulation on nocturnal movements in Parkinson's disease.

Phase 4
Recruiting
Conditions
difficulty turning around in bed
nocturnal hypokinesia
10040998
Registration Number
NL-OMON35536
Lead Sponsor
Centrum voor Slaapgeneeskunde Kempenhaeghe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Patients with idiopathic PD
Patients who will start treatment with rotigotine
Hoehn & Yahr stage II - IV
Subjective sleep problems most likely caused by nocturnal hypokinesia

Exclusion Criteria

Other significant causes for nocturnal motor symptoms which are not dopamine-responsive
Previous surgery for PD
Mini- mental state examination score < 25
Concurrent hallucination or psychosis
History of skin hypersensitivity to adhesives or other transdermals

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Position changes over the night. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Objective<br /><br>• Degree of mobility, measured as the speed of the movements<br /><br>• Total amount of movements<br /><br>• Score on the motor symptom scale according to the MDS-UPDRS part III<br /><br><br /><br>Subjective<br /><br>• Nocturnal sleep quality<br /><br>Excessive daytime sleepiness<br /><br>• Presence of nocturnal akinesia </p><br>
© Copyright 2025. All Rights Reserved by MedPath